January 6, 2026 — Leads & Copy — Robert Lyne, Chief Executive Officer of PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), is scheduled to present at the 44th annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 4:30pm PST / 7:30pm EST.
PureTech Health, a biotherapeutics company focused on transforming innovation into value, announced the upcoming presentation. A webcast of the presentation will be available at https://investors.puretechhealth.com.
PureTech Health operates as a hub-and-spoke biotherapeutics company, channeling its efforts into translating scientific advancements into practical applications. The company’s R&D model is designed to be capital-efficient, targeting opportunities with validated pharmacology to address unmet patient needs. This approach has led to the development of multiple therapeutic candidates, including three that have secured U.S. FDA approval.
By identifying, shaping, and de-risking high-potential assets and scaling them through dedicated structures, PureTech aims to expedite their availability to patients and generate value for shareholders.
For more information, visit www.puretechhealth.com or connect with us on X (formerly Twitter) @puretechh.
Source: PureTech Health
